Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Schenone S et al. – The authors will report the most interesting second–generation Abl and dual Src/Abl inhibitors recently entered in clinical trial, but also the new ATP–competitive and uncompetitive inhibitors published in the last few years, focusing on their chemical structure, mechanism of action, and structure–activity relationship.

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address